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Abbreviations
and Acronyms
CI = conﬁdence interval
MI = myocardial infarction
PCI = percutaneous coronary
intervention
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615Several groups of investigators have developed statistical
models to predict short-term mortality for patients with
percutaneous coronary interventions (PCIs) (1–11). Many of
these studies provide logistic regression models that could be
used with online risk calculators or personal digital assistants
(1,3,4,7,8). However, many clinicians still prefer risk scores
(risk indices) that enable referring and treating clinicians to
quickly sum up points assigned to each risk score, and use
a table that assigns a predicted probability of short-term
mortality associated with each score (2,5,6,9). All of these
risk scores for PCI have been limited to prediction of
in-hospital mortality (2,5,6,9). This is problematic because
a recent study has demonstrated that nearly two-thirds as
many PCI patients die after discharge but within 30 days
after the index procedure as the patients who die in the index
admission (7).
See page 623
The purpose of this study is to develop a PCI risk score for
in-hospital/30-day mortality. The score is developed using
a large population-based registry in New York, the Percuta-
neous Coronary Interventions Reporting System (PCIRS),
which has been in existence since 1992. Although an earlier
PCI risk scorewas created using PCIRS, 30-daymortality after
discharge was not available at that time. This is a critical
omission in that and other risk scores that are limited to in-
hospital mortality, given the very short length of stay for most
PCI patients and the relatively high mortality rate for them
within the ﬁrst month after the procedure (9).
Methods
Databases. The data in the study were obtained from the
PCIRS in 2009 and 2010. The PCIRS is a population-
based registry founded in 1992 by the New York State
Department of Health that contains detailed information on
all PCIs performed in nonfederal hospitals in New York.
Information in the registry includes lesion and vessel-speciﬁc
data, demographics, risk factors, complications, discharge
destination, and types of devices used, as well as hospital and
physician identiﬁers. In-hospital mortality is one of the
options for discharge status. The completeness of PCIRS
data is assured by matching it to New York’s administrative
database, the Statewide Planning and Research Cooperative
System (SPARCS), which contains information on both
inpatient and outpatient PCIs. Accuracy of in-hospital
mortality is conﬁrmed by matching with SPARCS, and the
accuracy of risk-factor reporting is assured by auditing
samples of records from hospitals.
In order to obtain deaths that occur with 30 days of the
index procedure after discharge, the PCIRS was linked to
New York vital statistics data and to the Social Security
Administration Master File.Patients. Patients in the system consisted of all patients
undergoing PCI in nonfederal hospitals in New York in
2010. The total number of patients in the study was 54,223.
To examine the validity of the risk model developed using
2010 data, the resulting statistical model was used to predict
outcomes for the 54,041 patients undergoing PCI in New
York in 2009.
Statistical methods. First, a logistic regression model was
used to predict in-hospital/30-day mortality (the dependent
variable) based on all of the available risk factors in the
PCIRS. The ﬁrst part of this process consisted of identifying
which of these risk factors had a signiﬁcant (p < 0.10)
bivariate relationship with the dependent variable. Risk factors
examined included age, sex, body mass index, body surface
area, pre-procedural myocardial infarction (MI), hemody-
namic state, ventricular function, number of vessels diseased,
left main disease, and numerous comorbidities. Continuous
variables such as age, body mass index, and body surface area
were tested using Student t tests and Wilcoxon rank-sum
tests; all other variables were tested using chi-square tests.
Risk factors that were signiﬁcantly related to the mortality
measure were then used as candidate independent variables
in subsequent logistic regression analyses. The database was
split into 2 halves so that each
half had roughly the same prev-
alence for various risk factors and
for the outcome rate. A stepwise
logistic regression model with in-
hospital/30-day mortality as the
dependent variable was ﬁt on the
ﬁrst half of the data, and risk
factors with a p value <0.10 were used as candidates in
another stepwise logistic regression model applied to the
second half of the data. Variables that emerged as signiﬁcant
in this model (p < 0.10) were then used as candidate
independent variables for the entire 2010 PCI database. The
variables that emerged as signiﬁcant (p < 0.05) in this model
were included in the ﬁnal model. In all models, continuous
variables were tested to determine which form (linear,
quadratic, linear spline) was most strongly associated with
mortality. The ﬁt of the ﬁnal model was evaluated on the
basis of discrimination using the c-statistic (10) and cali-
bration using the Hosmer-Lemeshow statistic (11).
We then converted the logistic regression model into a
PCI risk score using the methods applied in our earlier
studies (9,12) that were ﬁrst described by Sullivan et al. (13).
First, the continuous variable (age), which was expressed in
terms of a linear spline function in the logistic regression
model, was split into ranges so that the risk score method-
ology could be applied. Groups were chosen so that the
mortality rates would be as similar as possible within groups
and as dissimilar as possible between groups. The ranges
chosen for age were <66, 66 to 75, 76 to 85, and 86þ years.
Reference values for ranges except the most extreme one
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616were chosen as the midpoints of the ranges (e.g., the refer-
ence group for the 66 to 75 age range was 70.5). For the
most extreme range at the other end of the spectrum from
the reference category (86þ), the reference value for the
group was chosen as the midpoint between the beginning of
the range and the 99th percentile of the range. The constant
corresponding to 1 point in the risk score was obtained by
multiplying one-half the length of each age range (10 years)
by the age coefﬁcient (5  0.0668 ¼ 0.334). For all other
risk factors, each of which was represented by 1 or more
categories in the logistic regression model, the coefﬁcient of
each category was divided by 0.334 and then rounded off to
the nearest integer. For example, the risk factor “MI within
6 to 11 h prior to procedure” had a coefﬁcient of 1.786, and
1.786/0.334 ¼ 5.35, which rounds to 5.
The total risk score for each patient was obtained by
summing the scores of all of the patient’s risk factors. For each
risk score, the probability of in-hospital/30-day mortality
was obtained by developing a new logistic regression model
using the risk score as the single independent variable and
mortality as the binary dependent variable. The predicted
value for each risk score was then obtained by plugging the
score into the model. The accuracy of the risk scores in
predicting mortality was examined by comparing, for every
risk score, the predicted mortality rate for all 2010 PCI
patients with that score with the observed mortality rate for
that risk score. Conﬁdence intervals were calculated for the
observed rates for the risk scores and the predicted values
for the scores were inspected to determine if they fell inside
the conﬁdence intervals. The same process was then used to
see how well the 2010 risk scores predicted mortality for
patients undergoing PCI in New York in 2009. Recalibration
was required before testing the 2010 risk scores on 2009
data because the underlying in-hospital/30-day mortality
rates were different. This was done by multiplying the pre-
dicted risk for each 2009 patient by the ratio of the 2009
observed mortality rate and the rate predicted for 2009 using
the 2010 logistic regression model. The resulting probabili-
ties are the recalibrated predicted risks for 2009 patients.
The correspondences between the PCI mortality risk
score and other adverse outcome measures (complications,
length of stay) were also examined for each measure by
plotting adverse outcome rates for each value of risk score to
determine whether there were higher values of the adverse
outcome measure as the risk score increased. Complications
analyzed included stroke, vessel injury at the catheter entry
site requiring intervention, and stent thrombosis.
All statistical analyses were conducted in SAS version 9.1
(SAS Institute, Cary, North Carolina).
Results
A total of 54,223 PCI patients who underwent PCI in a total
of 58 hospitals were used to develop the risk index. Thein-hospital/30-day mortality rate for these patients was
1.03%. Table 1 presents bivariate relationships between risk
factors in the registry and the presence of in-hospital/30-day
mortality for PCI. The signiﬁcant independent risk factors
in the logistic regression model for mortality included age,
hemodynamic instability, ejection fraction, pre-procedural
MI (with and without ST-segment elevation), peripheral
vascular disease, congestive heart failure, malignant ventric-
ular arrhythmia, chronic obstructive pulmonary disease, renal
failure, 2 or 3 vessels diseased, and left main disease (Table 2).
All variables except age, ejection fraction, MI, and renal
failure are binary variables, and ejection fraction, MI, and
renal failure are categorical variables with more than 2 cate-
gories. Age was represented as linear spline functions, with
the risk for age ﬂat until age 66 and rising thereafter. The c-
statistic for the logistic regression model was 0.89 and the
Hosmer-Lemeshow statistic was 16.11, indicating excellent
discrimination and fair calibration.
Scores for the various risk factors are presented in Table 3.
As indicated, the highest scores were associated with shock
(9 points) and ST-segment elevation MI 12 to 23 h before
admission (8 points). The minimum possible risk score is
0 points for a patient without any of the risk factors listed in
Table 3, and the maximum possible risk score is 43. The
highest score for any patient in 2010 was 34. As noted in
Table 4, the predicted probabilities of in-hospital/30-day
mortality ranged from 0.09% for a risk score of 0, to 98.74%
for a risk score of 34. As an example of how the risk score can
be used, a 70 year old who is hemodynamically stable, has an
ejection fraction of 40%, had an MI without ST-segment
elevation 5 days before admission, and has peripheral vascular
disease, no congestive heart failure, no malignant ventricular
arrhythmia, no renal failure, and 2-vessel disease would have
a total risk score of 1þ 1þ 3 þ1þ 1¼ 7. From Table 4, the
predicted probability of in-hospital/30-day mortality for this
patient would be 0.94%.
Figure 1 demonstrates the correspondence between ob-
served and predicted rates for each risk score where observed
and predicted rates were obtained from 2010 data. As the
ﬁgure demonstrates, the observed and predicted values are
quite close together, and the predicted rates fall within
the 95% conﬁdence interval (CI) for the observed rates for
each of the risk score ranges in the ﬁgure except for a risk
score of 13 to 14, for which the predicted rate (7.89%) was
slightly below the lower bound of the observed rate (7.95%).
Figure 2 examines the same correspondence, except that it
is restricted to patients with an acute MI (onset within 24 h
of the PCI). For each of the ranges of risk scores, the pre-
dicted mortality rates were within the 95% CIs for the
observed mortality rates except for scores of 13 to 14, where
the predicted mortality rate was 7.93% and the lower bound
for the CI for the observed mortality rates was 8.94%.
Figure 3 contrasts the observed rates for each risk score
in the year 2009 with the predicted values based on the
Table 1. Bivariate Relationship Between Predictor Variables for In-Hospital/30-Day Mortality;
PCI in New York State in 2010 (N ¼ 54,223)
Risk Factor Prevalence Mortality p Value
Age, yrs
65 28,242 (52.08) 0.61 <0.0001
66–75 14,870 (27.42) 1.00
76–85 9,381 (17.30) 1.79
86þ 1,730 (3.19) 4.05
Sex
Male 37,472 (69.11) 0.86 <0.0001
Female 16,751 (30.89) 1.39
Hemodynamic state
Stable 53,809 (99.24) 0.81 <0.0001
Unstable 253 (0.47) 16.60
Shock 161 (0.30) 48.45
Ejection fraction
50% or missing (reference) 40,559 (74.80) 0.63 <0.0001
<20% 415 (0.77) 9.40
20%–29% 1,934 (3.57) 4.34
30%–49% 11,315 (20.87) 1.57
Pre-procedural MI
No MI within 1 day (reference) 39,998 (73.77) 0.35 0<.0001
MI with ST-segment elevation <6 h 4,316 (7.96) 4.82
MI with ST-segment elevation 6–11 h 842 (1.55) 3.56
MI with ST-segment elevation 12–23 h 481 (0.89) 5.82
MI without ST-segment elevation <6 h 363 (0.67) 2.75
MI without ST-segment elevation 6–11 h 481 (0.89) 2.29
MI without ST-segment elevation 2–23 h 917 (1.69) 1.31
MI with or without ST-segment elevation 1–14 days 6,825 (12.59) 1.73
Peripheral vascular disease
Yes 4,765 (8.79) 2.06 <0.0001
No 49,458 (91.21) 0.93
Malignant ventricular arrhythmia
Yes 326 (0.60) 12.27 <0.0001
No 53,897 (99.40) 0.96
COPD
Yes 3,568 (6.58) 1.91 <0.0001
No 50,655 (93.42) 0.97
Congestive heart failure
Current 2,961 (5.46) 4.90 <0.0001
Past 1,526 (2.81) 1.97
None 49,736 (91.72) 0.77
Renal failure
No renal failure (reference) 48,752 (89.91) 0.76 <0.0001
Renal failure, creatinine 1.6–2.0 mg/dl 2,934 (5.41) 2.56
Renal failure, creatinine >2.1 mg/dl 1,231 (2.27) 4.71
Renal failure, requiring dialysis 1,306 (2.41) 4.21
Vessels diseased
None or 1 29,285 ( 54.01) 0.74 <0.0001
2 Vessels diseased 17,378 (32.05) 1.15
3 Vessels diseased 7,560 (13.94) 1.88
Left main disease
Yes 2,142 (3.95) 2.80 <0.0001
No 52,081 (96.05) 0.95
Values are n (%).
COPD ¼ chronic obstructive pulmonary disease; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention.
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Table 2. Logistic Regression Equation for PCI In-Hospital/30-Day Deaths in New York State in 2010
(N ¼ 54,223)*
Risk Factor Prevalence Coefﬁcient Odds Ratio (95% CI) p Value
Demographic
Age, >65 yrs d 0.0668 1.069 (1.057–1.081) <0.0001
Females 30.89 0.3643 1.439 (1.189–1.743) 0.0002
Hemodynamic state
Unstable 0.47 1.3803 3.976 (2.683–5.892) <0.0001
Shock 0.30 2.9540 19.183 (13.111–28.066) <0.0001
Ejection fraction
50% (reference) 74.79 d 1.000 d
<20% 0.77 1.2621 3.533 (2.254–5.537) <0.0001
20%–29% 3.57 0.7421 2.100 (1.558–2.832) <0.0001
30%–49% 20.87 0.2308 1.260 (1.020–1.556) 0.0323
Pre-procedural MI
No MI within 1 day (reference) 73.76 d 1.000 d
MI with ST-segment elevation
MI <6 h 7.96 2.4544 11.640 (9.062–14.951) <0.0001
MI 6–11 h 1.55 2.0909 8.092 (5.163–12.684) <0.0001
MI 12–23 h 0.89 2.7153 15.109 (9.481–24.078) <0.0001
MI without ST-segment elevation
MI < 6 h 0.67 1.2754 3.580 (1.691–7.582) 0.0009
MI 6–11 h 0.89 1.7860 5.966 (3.092–11.511) <0.0001
MI 12–23 h 1.69 1.1998 3.319 (1.756–6.275) 0.0002
MI with or without ST-segment elevation
MI 1–14 days 12.59 1.0206 2.775 (2.133–3.609) <0.0001
Comorbidities
Peripheral vascular disease 8.79 0.3392 1.404 (1.089–1.810) 0.0089
CHFdcurrent 5.46 0.8184 2.267 (1.764–2.912) <0.0001
CHFdpast 2.81 0.5361 1.709 (1.127–2.593) 0.0117
Malignant ventricular arrhythmia 0.60 1.1985 3.315 (2.167–5.071) <0.0001
COPD 6.58 0.5651 1.760 (1.329–2.329) <0.0001
Renal failure
No renal failure (reference) 89.91 d 1.000 d
Renal failure, creatinine 1.6–2.0 mg/dl 5.41 0.5584 1.748 (1.314–2.326) 0.0001
Renal failure, creatinine >2.1 mg/dl 2.27 1.1411 3.130 (2.235–4.384) <0.0001
Renal failure, requiring dialysis 2.41 1.6087 4.996 (3.576–6.980) <0.0001
Vessels diseased
2 vessels diseased 32.05 0.2564 1.292 (1.047–1.595) 0.0169
3 vessels diseased 13.94 0.4541 1.575 (1.241–1.998) 0.0002
Left main disease 3.95 0.4929 1.637 (1.195–2.242) 0.0021
*Intercept ¼ 6.9970.
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
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6182010 risk model after recalibrating the 2009 risk score
probabilities to reﬂect the differences in performance
between 2009 and 2010. The predicted values and observed
values again demonstrate a very good correspondence, with
the predicted values for all risk score ranges falling within the
corresponding 95% CI for the observed value for all ranges,
except score ¼ 1, where the predicted rate (0.13%) was
slightly above the upper bound for the observed rate
(0.12%). Figure 4 examines the ability of the 2010 statistical
model to predict mortality for the 2009 acute MI patients.As indicated, for all ranges of risk scores used, the predicted
mortality rates fell within the 95% CI for the observed
mortality rates.
Figure 5 examines the correspondence between the 2010
risk score and the probability of 1 or more post-procedural
complications (from stroke, stent thrombosis, and vessel
injury at the catheterization site) in the index admission. As
noted, the complication rate rises or remains the same with
each increase in risk score, with the lowest complication rate
(0.3%) corresponding to a risk score of 0, and the highest
Table 3. Risk Scores for In-Hospital/30-Day Mortality for PCI*
Risk Factor Score
Demographic
Age, yrs
66–75 1
76–85 3
86 and older 5
Female 1
Hemodynamic state
Unstable 4
Shock 9
Ejection fraction
<20% 4
20%–29% 2
30%–49% 1
Pre-procedural MI
MI with ST-segment elevation
MI <6 h 7
MI 6–11 h 6
MI 12–23 h 8
MI without ST-segment elevation
MI <6 h 4
MI 6–11 h 5
MI 12–23 h 4
MI with or without ST-segment elevation
MI 1–14 days 3
Comorbidities
Peripheral vascular disease 1
CHFdcurrent or past 2
Malignant ventricular arrhythmia 4
COPD 2
Renal failure
Renal failure, creatinine 1.6–2.0 mg/dl 2
Renal failure, creatinine >2.1 mg/dl 3
Renal failure, requiring dialysis 5
Vessels diseased
2 or 3 vessels diseased 1
Left main disease 1
*The highest observed total risk score was 34. The highest theoretical risk score was 43.
Abbreviations as in Table 1.
Table 4. Predicted Risk of In-Hospital/30-Day Mortality Associated With
Individual Risk Scores and the Distribution of Total Risk Score Among PCI
Patients in New York State in 2010 (N ¼ 54,223)
Total Risk
Score*
Predicted
Risk (%)
Cumulative Percentage of Patients
With This Risk Score or Less (%)
0 0.09 10.8
1 0.13 29.3
2 0.18 43.0
3 0.25 53.1
4 0.35 64.0
5 0.48 71.7
6 0.67 77.3
7 0.94 82.8
8 1.31 87.9
9 1.81 92.0
10 2.52 94.4
11 3.48 96.2
12 4.79 97.4
13 6.57 98.3
14 8.94 98.8
15 12.06 99.2
16 16.07 99.4
17 21.10 99.6
18 27.19 99.7
19 34.28 99.7
20 42.14 99.8
21 50.42 99.9
22 58.69 99.9
23 66.49 99.9
24 73.48 100.0
25 79.46 100.0
26 84.38 100.0
27 88.30 100.0
28 91.33 100.0
29 93.64 100.0
30 95.36 100.0
31 96.63 100.0
32 97.57 100.0
33 98.25 100.0
34 98.74 100.0
35 99.09 d
36 99.35 d
37 99.53 d
38 99.66 d
39 99.76 d
40 99.83 d
41 99.88 d
42 99.91 d
43 99.94 d
*The highest observed total risk score was 34. The highest theoretical risk score was 43.
PCI ¼ percutaneous coronary intervention.
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619complication rate (2.2%) associated with patients with a risk
score of 15 or higher. The c-statistic for complications was
a modest 0.67.
Figure 6 shows that there is a reasonably good corre-
spondence between the 2010 risk score and the 2010 post-
procedural length of stay. The length of stay rises from amean
of 1.1 days for patients with a risk score of 0 or 1, to a mean
of 8.7 days for patients with a risk score of 15 or higher.
Discussion
Risk scores are simpliﬁed, usually additive, scores that assign
a speciﬁed number of points to important risk factors so thatthe sum of the scores can be assigned to predicted (usually
short-term) mortality rates following a given procedure. The
primary purpose of a PCI risk score of this nature is to
enable referring cardiologists and patients to assess the
Figure 1. Observed and Predicted Risk of In-Hospital/30-Day
Mortality by Total Risk Scores for All PCI Patients in New York State,
2010 (N ¼ 53,893)
Predicted and observed rates based on 2010 data. Solid black line across
each bar ¼ 95% conﬁdence interval of observed risk. OMR ¼ observed
mortality rate; PCI ¼ percutaneous coronary intervention; PMR ¼ predicted
mortality rate.
Figure 3. Observed and Predicted Risk of In-Hospital/30-Day
Mortality by Total Risk Score for All PCI Patients in New York State,
2009 (N ¼ 54,990)
Predicted rates based on 2010 data after recalibrating 2009 risk score prob-
abilities. Solid black line across each bar ¼ 95% conﬁdence interval of
observed risk. PCI ¼ percutaneous coronary intervention; other abbreviations
as in Figure 1.
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620patients’ chances of short-term survival after PCI for the
purpose of informed consent and as an aid to determining
whether PCI is the best intervention for each patient. It is
also valuable in assessing the additional risk associated with
individual risk factors for short-term survival.Figure 2. Observed and Predicted Risk of In-Hospital/30-Day Mortality
by Total Risk Scores for PCI Patients Who Had an Acute MI Before
Procedures in New York State, 2010 (N ¼ 7,208)
Predicted and observed rates based on 2010 data. Solid black line across each
bar ¼ 95% conﬁdence interval of observed risk. MI ¼ myocardial infarction;
PCI ¼ percutaneous coronary intervention; other abbreviations as in Figure 1.This study was conducted to update a PCI risk score
developed in New York a few years ago in order to provide
more contemporary data for prediction purposes. More
importantly, the previous New York risk score was devel-
oped using in-hospital mortality as the outcome measure (9),Figure 4. Observed and Predicted Risk of In-Hospital/30-Day Mortality
by Total Risk Scores for PCI Patients Who Had an Acute MI Before
Procedures in New York State, 2009 (N ¼ 7,036)
Solid black line across each bar ¼ 95% conﬁdence interval of observed risk.
Abbreviations as in Figures 1 and 2.
Figure 5. Complication Rate by Total Risk Score for PCI Patients in
New York State, 2009 (N ¼ 53,893)
PCI ¼ percutaneous coronary intervention.
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621and to the best of our knowledge, this is also true of most
other PCI short-term risk scores (2,5,6). However, much of
the early mortality following PCI occurs after discharge
following the index procedure because of the short length of
stay that is typical of PCI. For example, in 2009 in New
York, the percentage of patients undergoing PCI who died
during the index hospitalization was 0.55%, and another
0.36% died after discharge, but within 30 days of the index
procedure. Thus, 0.36/(0.36 þ 0.55) ¼ 40% of all short-
term deaths occurred after discharge within 30 days of the
index procedure (7). Consequently, it is important to be able
to predict short-term out-of-hospital deaths for the purposes
of informed consent and procedure choice. The purpose of
this study was to develop a risk score that accurately predicts
all short-term deaths, in and outside of the hospital.Figure 6. Length of Stay by Total Risk Score for PCI Patients in
New York State, 2009 (N ¼ 53,893)
PCI ¼ percutaneous coronary intervention.Our previous PCI risk score that used in-hospital
mortality as the outcome rather than in-hospital/30-day
mortality was based on a mortality rate of 0.70%, whereas
the risk score presented here, based on in-hospital/30-day
mortality, had an adverse outcome rate of 1.03%. Never-
theless, many of the risk factors represented in the score were
identical: age, female sex, hemodynamic instability, shock,
ejection fraction, pre-procedural MI, peripheral vascular
disease, renal failure, and left main disease were all repre-
sented in both risk scores. All risk factors represented in the
old score were represented in the new score. However, there
were 3 risk factors in the new risk score that were not
contained in the previous score: malignant ventricular
arrhythmia, chronic obstructive pulmonary disease, and 2/3
vessel disease. The risk factors with the highest score in the
original risk score based on in-hospital mortality were shock
and MI <24 h with stent thrombosis (each with 9 points).
In the new risk score, the risk factors with the highest scores
were shock (9 points) and ST-segment elevation MI 12 to
23 h before admission (8 points).
We found that the risk score developed in this study,
a very simpliﬁed estimate of the logistic regression predic-
tion, does predict in-hospital/30-day mortality quite accu-
rately for the database (2010 in New York) on which the
estimate was developed, and also predicts well for another
year (2009) of PCI data in New York. For example, the
c-statistic of 0.89 of the logistic regression model was very
similar to the 0.90 c-statistic of Hamburger et al. (1), and
comparisons of observed and predicted mortality rates for
various ranges of risk scores conﬁrmed that they were
generally not statistically different. Our c-statistic also
compares favorably to the 0.762 value obtained by Shahian
et al. (14) for 30-day mortality, although it should be noted
that their study was limited to patients aged 65 and older,
and this may have limited the discriminatory power of
their model. It is notable that our risk score did not ﬁt as
accurately as our earlier risk score that was developed for
just in-hospital mortality, and we postulate that this is in
part due to the difﬁculty of ﬁtting a statistical model to
2 types of patient deaths (in-hospital and after discharge
within 30 days of the procedure). Nonetheless, we feel that
this risk score is more valuable in that it includes all deaths
within 30 days, a duration of time that is aligned with
patients’ and providers’ understanding of “early outcome” as
a basis upon which to make informed decisions.
As noted in Table 3, more than 90% of the patients
undergoing PCI had a risk score of 9 or less, and more than
70% had a score of 5 or less, with a predicted short-term
mortality of <0.5%. Thus, for a large proportion of patients,
the short-term mortality risk is not a deterrent in choosing
PCI in lieu of a competing intervention.
To determine whether the risk score we developed is
generalizable, it should be tested against other populations.
The means by which it should be tested depends on the
Hannan et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 6 , 2 0 1 3
The New York PCI Risk Index J U N E 2 0 1 3 : 6 1 4 – 2 2
622purpose of the risk score. The 2 main purposes for which
risk scores have been used are: 1) to compare the perfor-
mance (risk-adjusted outcome) in another population with
the performance in the population in which the risk score
was developed; and 2) to predict the bedside risk of a speciﬁc
patient in the new population for purposes of informed
consent and as an aid in treatment determination. For the
ﬁrst purpose, it is probably better to use a logistic regression
model like those published in New York’s annual reports
because although not as easy to use, these models provide
more exact estimates of predicted mortality (7).
The second purpose should be the primary use of a risk
score, but to use the score appropriately for this purpose, the
score should be recalibrated in order to make it more rele-
vant in the other setting, which may have a signiﬁcantly
different risk-adjusted mortality rate. When used as an aid to
treatment determination, it would ideally be used in
conjunction with other considerations (e.g., longer-term
mortality, symptom relief).
The recalibration process consists of calculating a new
mortality rate for each risk score in the other population by
multiplying the observed mortality rate for the New York
(2010) population by the ratio of the observed mortality rate
in the other population divided by the rate of the other
population predicted by the New York risk score (the mean
of the predicted probabilities of mortality for all patients in
the other population). This recalibrated score can then be
used to predict the probability of short-term mortality for
each patient in the other population.
An advantage of the New York risk score is that it is
based on data from all 58 New York State nonfederal
hospitals in which PCI was performed in 2010. We used
population-based data that included virtually all PCIs in
a large region (New York State) in the analyses. Use of such
a database contributes to the accuracy and generalizability of
our ﬁndings. Furthermore, the completeness of the database
has been veriﬁed by matching it to New York’s adminis-
trative database, and the accuracy of the data has been
enhanced by matching to this administrative data and to
vital statistics data, and by extensive auditing by New York’s
utilization review agent. The use of vital statistics data to
conﬁrm 30-day deaths outside of the hospital is particularly
important because we found that hospitals grossly under-
report 30-day deaths. We also found that, as did our
previous risk score limited to in-hospital mortality, this risk
score performed reasonably well as a predictor of compli-
cation rate and of length of stay. However, any attempts
to predict complications and length of stay with strongaccuracy should involve developing separate risk scores for
these adverse outcomes.
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